Occupational health guidelines for remediation workers at Bacillus anthracis-contaminated sites--United States, 2001-2002
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

All these words:

For very narrow results

This exact word or phrase:

When looking for a specific result

Any of these words:

Best used for discovery & interchangable words

None of these words:

Recommended to be used in conjunction with other fields

Language:

Dates

Publication Date Range:

to

Document Data

Title:

Document Type:

Library

Collection:

Series:

People

Author:

Help
Clear All

Query Builder

Query box

Help
Clear All

For additional assistance using the Custom Query please check out our Help Page

i

Occupational health guidelines for remediation workers at Bacillus anthracis-contaminated sites--United States, 2001-2002

  • 09/06/2002

  • Source: MMWR. Morbidity and mortality weekly report. 2002; 51(35):786-9.
Filetype[PDF-219.61 KB]


  • English
    • Details Related Documents You May Also Like

    Details:

    • Alternative Title:
      MMWR. Morbidity and mortality weekly report
    • Description:
      Despite the apparently low disease rate from exposure, protection for remediation workers at B. anthracis-contaminated sites is warranted because inhalational anthrax is rapidly progressive and highly fatal, PPE does not guarantee 100% protection, and the risk for developing disease cannot be characterized adequately. The guidelines described here go beyond HAZWOPER requirements and include recommendations for treating inhalation exposure to B. anthracis spores as a medical emergency, medical follow-up as long as the risk for anthrax persists or a worker is receiving antibiotic prophylaxis, accommodation of a mobile workforce, and assurance that workers understand the need for immediate medical attention should symptoms of anthrax occur. Completion of the 6-dose series of anthrax vaccine followed by annual booster doses will decrease the reliance on antibiotics for the prevention of anthrax. Measures to protect workers must include both medical measures (i.e., vaccination, antibiotic prophylaxis, or a combination of both) and measures to prevent exposure (e.g., PPE and environmental controls).
    • Subject:
    • Source:
      MMWR. Morbidity and mortality weekly report. 2002; 51(35):786-9.
    • Document Type:
      Journal Issue
    • Place as Subject:
      United States
    • Collection(s):
      Guidelines and Recommendations
    • Main Document Checksum:
    • File Type:

    Supporting Files

    • No Additional Files

    More +

    Related Documents

    This document has replaced (most recent first):
      CDC updates interim guidelines for anthrax exposure management and antimicrobial therapy
      Cite
      Filetype[HTM]
      Personal Author:
      Ressel, Genevieve
      December 1, 2001 | American family physician. 2001; 64(11):1901-2, 1904.
      Description:
      The Centers for Disease Control and Prevention (CDC) has issued an update on the investigation of recent cases of anthrax exposure. This update includ...
      Status:
      superseded
      File Type:
      Filetype[HTM]
      File Type:
      Filetype[HTM]
      Use of anthrax vaccine in response to terrorism : supplemental recommendations of the Advisory Committee on Immunization Practices
      Cite
      Filetype[PDF - 849.94 KB]
      Corporate Authors:
      United States. Advisory Committee on Immunization Practices. ...
      November 15, 2002 | MMWR. Morbidity and mortality weekly report. 2002; 51(45):1024-6.
      Description:
      In December 2000, the Advisory Committee on Immunization Practices (ACIP) released its recommendations for using anthrax vaccine in the United States....
      Status:
      superseded
      File Type:
      Filetype[PDF - 849.94 KB]
      File Type:
      Filetype[PDF - 849.94 KB]
      From the Centers for Disease Control and Prevention. Use of anthrax vaccine in response to terrorism : supplemental recommendations of the Advisory Committee on Immunization Practices
      Cite
      Filetype[PDF - 79.88 KB]
      Corporate Authors:
      Centers for Disease Control and Prevention (U.S.) ...
      December 4, 2002 | JAMA : the journal of the American Medical Association. 2002; 288(21):2681-2.
      Description:
      No Description
      Status:
      superseded
      File Type:
      Filetype[PDF - 79.88 KB]
      File Type:
      Filetype[PDF - 79.88 KB]

    You May Also Like

    Checkout today's featured content at stacks.cdc.gov